Renaissance Technologies’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-153,000
Closed -$1.58M 4278
2023
Q3
$1.58M Sell
153,000
-200
-0.1% -$1.9K ﹤0.01% 2006
2023
Q2
$1.26M Buy
153,200
+113,500
+286% +$679K ﹤0.01% 2321
2023
Q1
$222K Sell
39,700
-30,900
-44% -$177K ﹤0.01% 3235
2022
Q4
$349K Sell
70,600
-115,800
-62% -$477K ﹤0.01% 3161
2022
Q3
$895K Buy
+186,400
New +$799K ﹤0.01% 2565
2022
Q2
Sell
-82,435
Closed -$475K 4663
2022
Q1
$475K Buy
+82,435
New +$740K ﹤0.01% 3229
2018
Q3
Sell
-62,100
Closed -$3.96M 3622
2018
Q2
$3.96M Buy
62,100
+18,200
+41% +$893K ﹤0.01% 1931
2018
Q1
$1.7M Sell
43,900
-42,800
-49% -$1.5M ﹤0.01% 2408
2017
Q4
$2.43M Buy
+86,700
New +$2.54M ﹤0.01% 2227

Other funds holding TRHC

Renaissance Technologies's TRHC Position: Q4 2023 in Review

Renaissance Technologies sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 153,000 shares — an estimated $1.58M sold.

Renaissance Technologies first reported a position in TRHC in Q4 2017 and held it in 9 quarters. The position peaked at $3.96M in Q2 2018. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.

  • Renaissance Technologies reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Renaissance Technologies sold 153,000 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $1.58M.
  • Renaissance Technologies first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2017 and held it in 9 quarters.
  • Renaissance Technologies's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $3.96M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.